AU2009901425A0 - Compositions and methods for treatment of aortic fibrosis - Google Patents
Compositions and methods for treatment of aortic fibrosisInfo
- Publication number
- AU2009901425A0 AU2009901425A0 AU2009901425A AU2009901425A AU2009901425A0 AU 2009901425 A0 AU2009901425 A0 AU 2009901425A0 AU 2009901425 A AU2009901425 A AU 2009901425A AU 2009901425 A AU2009901425 A AU 2009901425A AU 2009901425 A0 AU2009901425 A0 AU 2009901425A0
- Authority
- AU
- Australia
- Prior art keywords
- compositions
- treatment
- methods
- aortic fibrosis
- aortic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 206010016654 Fibrosis Diseases 0.000 title 1
- 230000004761 fibrosis Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Priority Applications (20)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI1006748A BRPI1006748A2 (en) | 2009-04-02 | 2010-04-06 | prophylactic or therapeutic treatment method for aortic fibrosis in an individual, vasoactive intestinal peptide (vip), use of vasoactive intestinal peptide (vip), method for reducing collagen formation or for enhancing collagen degradation in an individual's ortho, and , composition for the prophylactic or therapeutic treatment of aortic fibrosis |
KR1020117025945A KR101627008B1 (en) | 2009-04-02 | 2010-04-06 | Compositions and methods for treatment of aortic fibrosis |
RU2011142268/15A RU2536223C2 (en) | 2009-04-02 | 2010-04-06 | Compositions and methods for treatment of aorta fibrosis |
US13/262,064 US8729020B2 (en) | 2009-04-02 | 2010-04-06 | Methods for the treatment of aortic fibrosis with VIP fragments |
NZ595726A NZ595726A (en) | 2009-04-02 | 2010-04-06 | Compositions and methods for treatment of aortic fibrosis |
EP10757953.4A EP2413954B1 (en) | 2009-04-02 | 2010-04-06 | Composition comprising vip or its active fragments for use in treating aortic fibrosis |
SG2011070778A SG174966A1 (en) | 2009-04-02 | 2010-04-06 | Compositions and methods for treatment of aortic fibrosis |
MYPI2011004649A MY180681A (en) | 2009-04-02 | 2010-04-06 | Compositions and methods for treatment of aortic fibrosis |
AU2010230862A AU2010230862B2 (en) | 2009-04-02 | 2010-04-06 | Compositions and methods for treatment of aortic fibrosis |
ES10757953.4T ES2462501T3 (en) | 2009-04-02 | 2010-04-06 | Composition comprising VIP or its active fragments for use in the treatment of aortic fibrosis |
MX2011010341A MX2011010341A (en) | 2009-04-02 | 2010-04-06 | Compositions and methods for treatment of aortic fibrosis. |
DK10757953.4T DK2413954T3 (en) | 2009-04-02 | 2010-04-06 | A composition comprising VIP or its active fragments for use in the treatment of aortic fibrosis |
CA2757076A CA2757076C (en) | 2009-04-02 | 2010-04-06 | Compositions and methods for treatment of aortic fibrosis comprising vasoactive intestinal peptide (vip) or functional vip fragments |
JP2012502396A JP5687266B2 (en) | 2009-04-02 | 2010-04-06 | Compositions and methods for the treatment of aortic fibrosis |
PCT/AU2010/000391 WO2010111753A1 (en) | 2009-04-02 | 2010-04-06 | Compositions and methods for treatment of aortic fibrosis |
CN2011800017312A CN102711797A (en) | 2009-04-02 | 2010-04-06 | Compositions and methods for treatment of aortic fibrosis |
IL215460A IL215460A (en) | 2009-04-02 | 2011-10-02 | Use of compositions comprising vip in the manufacture of medicaments for prophylactic or therapeutic treatment of aortic fibrosis |
ZA2011/07820A ZA201107820B (en) | 2009-04-02 | 2011-10-25 | Compositions and methods for treatment of aortic fibrosis |
HK12105842.5A HK1165271A1 (en) | 2009-04-02 | 2012-06-14 | Composition comprising vip or its active fragments for use in treating aortic fibrosis |
US14/252,818 US20140235541A1 (en) | 2009-04-02 | 2014-04-15 | Compositions and methods for treatment of aortic fibrosis |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2009901425A0 true AU2009901425A0 (en) | 2009-04-23 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2482814A4 (en) | Methods and compositions for treatment of ocular fibrosis | |
AU2009221838A8 (en) | Implants and methods of use | |
PL2182981T3 (en) | Methods and compositions for treatment and diagnosis of fibrosis | |
EP2615932A4 (en) | Compositions and methods of treating edible matter and substrates therefor | |
EP2429948A4 (en) | Aerogel compositions and methods of making and using them | |
EP2603202A4 (en) | Compositions and methods for treatment of taupathy | |
EP2533926A4 (en) | Bur and method of making same | |
HK1166305A1 (en) | Compositions and methods for the treatment of inflammation | |
IL214455A0 (en) | Methods and compositions for treatment of neovascularization | |
WO2010123759A9 (en) | Compositions and methods for treating burns | |
AU2010260585A8 (en) | Compositions and methods for treatment of Multiple Sclerosis | |
IL247929B (en) | Stable sns-595 compositions and methods of preparation | |
ZA201203060B (en) | Composition and method of delivery | |
ZA201107820B (en) | Compositions and methods for treatment of aortic fibrosis | |
EP2563923A4 (en) | Compositions and methods for reduced scarring and for treatment of fibrosis | |
EP2462131A4 (en) | Compositions and methods for treating beta-amyloid related diseases | |
AU2009901425A0 (en) | Compositions and methods for treatment of aortic fibrosis | |
AU2009901447A0 (en) | Composition and method of treatment | |
AU2010902965A0 (en) | Antipsoratic composition and method of treatment | |
AU2010901445A0 (en) | Composition and method of treatment | |
AU2009904460A0 (en) | Methods of treatment | |
AU2009902633A0 (en) | Methods of treatment | |
AU2009905173A0 (en) | Methods of treatment | |
AU2009903360A0 (en) | Method of Treatment | |
AU2009905930A0 (en) | Methods and Preparation and Uses of Xanthorrhoeaceae Compositions |